Evidence map›Paper›PMID 30575436›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2019

Cardioprotection via the skin: nociceptor-induced conditioning against cardiac MI in the NIC of time.

Xiaoping Ren, Anne E Roessler, Thomas L Lynch, Lauren Haar, Faryal Mallick, Yong Lui, Michael Tranter, Michelle Huan Ren, Wen Rui Xie, Guo-Chang Fan and 11 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Guidelines for in vivo mouse models of myocardial infarction.American journal of physiology. Heart and circulatory physiology · 2021
    Guideline
  2. Article
  3. Review
  4. Capsaicin: Emerging Pharmacological and Therapeutic Insights.Current issues in molecular biology · 2024
    Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 5 institutions in 1 country.

Xiaoping RenDepartment of Molecular Pharmacology and Therapeutics, Loyola University Chicago, Mawood, Illinois.
Anne E RoesslerDepartment of Molecular Pharmacology and Therapeutics, Loyola University Chicago, Mawood, Illinois.
Thomas L LynchDepartment of Molecular Pharmacology and Therapeutics, Loyola University Chicago, Mawood, Illinois.
Lauren HaarDepartment of Molecular Pharmacology and Therapeutics, Loyola University Chicago, Mawood, Illinois.
Faryal MallickDivision of Cardiology, Department of Medicine, University of Cincinnati College of Medicine , Cincinnati, Ohio.
Yong LuiDivision of Cardiology, Department of Medicine, University of Cincinnati College of Medicine , Cincinnati, Ohio.
Michael TranterDivision of Cardiology, Department of Medicine, University of Cincinnati College of Medicine , Cincinnati, Ohio.
Michelle Huan RenDivision of Cardiology, Department of Medicine, University of Cincinnati College of Medicine , Cincinnati, Ohio.
Wen Rui XieDepartment of Anesthesiology and Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio.
Guo-Chang FanDepartment of Pharmacology, University of Cincinnati , Cincinnati, Ohio.ORCID 0000-0002-0439-8277
Jun-Ming ZhangDepartment of Anesthesiology and Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio.
Evangelia G KraniasDepartment of Pharmacology, University of Cincinnati , Cincinnati, Ohio.
Ahmad AnjakDivision of Cardiology, Department of Medicine, University of Cincinnati College of Medicine , Cincinnati, Ohio.
Sheryl KochDivision of Cardiology, Department of Medicine, University of Cincinnati College of Medicine , Cincinnati, Ohio.
Min JiangDivision of Cardiology, Department of Medicine, University of Cincinnati College of Medicine , Cincinnati, Ohio.
Qing MiaoDepartment of Molecular Pharmacology and Therapeutics, Loyola University Chicago, Mawood, Illinois.
Yang WangDepartment of Molecular Pharmacology and Therapeutics, Loyola University Chicago, Mawood, Illinois.
Albert CohenDepartment of Mathematics, Michigan State University , East Lansing, Michigan.
Jack RubinsteinDivision of Cardiology, Department of Medicine, University of Cincinnati College of Medicine , Cincinnati, Ohio.
Neal L WeintraubDivision of Cardiology, Georgia Regents University, Augusta, Geogia.
W Keith JonesDepartment of Molecular Pharmacology and Therapeutics, Loyola University Chicago, Mawood, Illinois.
University of Cincinnati Medical Center · USLoyola University Chicago · USUniversity of Cincinnati · USAugusta University · USMichigan State University · US

Funding

Roles of Hsp20-Exosomes in Myocardial AngiogenesisR01HL087861 · NHLBI · UNIVERSITY OF CINCINNATI · PI FAN, GUO-CHANG · 2007 to 2017
$4.2M
Innovative Approaches to Treat Duchenne Muscular Dystrophy Using iPSC-Derived Muscle ProgenitorsR01AR070029 · NIAMS · AUGUSTA UNIVERSITY · PI ASHRAF, MUHAMMAD, TANG, YAO LIANG · 2016 to 2021
$2.6M
Investigation of Human Antigen R (HuR) as a Novel Mediator of Cardiac HypertrophyR01HL132111 · NHLBI · UNIVERSITY OF CINCINNATI · PI TRANTER, MICHAEL · 2016 to 2020
$1.8M
Epigenetic regulation of HDAC9 in obesity and atherosclerosisR01HL126949 · NHLBI · AUGUSTA UNIVERSITY · PI WEINTRAUB, NEAL L · 2016 to 2019
$1.8M
Tsg101 and endosomes in cardiac surgery-induced injuryR01GM126061 · NIGMS · UNIVERSITY OF CINCINNATI · PI FAN, GUO-CHANG · 2018 to 2021
$1.2M
Roles of Sectm1a in macrophages and cardiac function during sepsisR01GM132149 · NIGMS · UNIVERSITY OF CINCINNATI · PI FAN, GUO-CHANG · 2019 to 2022
$1.2M
NHLBI NIH HHS R01 HL087861NHLBI NIH HHS R01 HL126949NHLBI NIH HHS R01 HL132111NIAMS NIH HHS R01 AR070029NIGMS NIH HHS R01 GM126061
6 · The paper itself

Abstract

Timely reperfusion is still the most effective approach to limit infarct size in humans. Yet, despite advances in care and reduction in door-to-balloon times, nearly 25% of patients develop heart failure postmyocardial infarction, with its attendant morbidity and mortality. We previously showed that cardioprotection results from a skin incision through the umbilicus in a murine model of myocardial infarction. In the present study, we show that an electrical stimulus or topical capsaicin applied to the skin in the same region induces significantly reduced infarct size in a murine model. We define this class of phenomena as nociceptor-induced conditioning (NIC) based on the peripheral nerve mechanism of initiation. We show that NIC is effective both as a preconditioning and postconditioning remote stimulus, reducing infarct size by 86% and 80%, respectively. NIC is induced via activation of skin C-fiber nerves. Interestingly, the skin region that activates NIC is limited to the anterior of the T9-T10 vertebral region of the abdomen. Cardioprotection after NIC requires the integrity of the spinal cord from the region of stimulation to the thoracic vertebral region of the origin of the cardiac nerves but does not require that the cord be intact in the cervical region. Thus, we show that NIC is a reflex and not a central nervous system-mediated effect. The mechanism involves bradykinin 2 receptor activity and activation of PKC, specifically, PKC-α. The similarity of the neuroanatomy and conservation of the effectors of cardioprotection supports that NIC may be translatable to humans as a nontraumatic and practical adjunct therapy against ischemic disease. NEW & NOTEWORTHY This study shows that an electrical stimulus to skin sensory nerves elicits a very powerful cardioprotection against myocardial infarction. This stimulus works by a neurogenic mechanism similar to that previously elucidated for remote cardioprotection of trauma. Nociceptor-induced conditioning is equally potent when applied before ischemia or at reperfusion and has great potential clinically.

Indexed as

NociceptionAnimalsCapsaicinCardiotonic AgentsFemaleMaleMiceMice, Inbred C57BLMyocardial InfarctionPeripheral NervesProtein Kinase CReceptor, Bradykinin B2ReflexSensory Receptor CellsSensory System AgentsSkinCapsaicinCardiotonic AgentsProtein Kinase CReceptor, Bradykinin B2Sensory System Agentscardioprotectionnociceptor-induced conditioningremote conditioningremote preconditioning of trauma

Identifiers

PMID30575436
PMCPMC6415820
OpenAlexW2906250014

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.